[HTML][HTML] Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study
Background Introduction of human papillomavirus (HPV) vaccination in settings with the
highest burden of HPV is not universal, partly because of the absence of quantitative …
highest burden of HPV is not universal, partly because of the absence of quantitative …
[PDF][PDF] Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study
M Jit, M Brisson, A Portnoy, R Hutubessy - 2014 - files.givewell.org
Background Introduction of human papillomavirus (HPV) vaccination in settings with the
highest burden of HPV is not universal, partly because of the absence of quantitative …
highest burden of HPV is not universal, partly because of the absence of quantitative …
[PDF][PDF] Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study
M Jit, M Brisson, A Portnoy, R Hutubessy - 2014 - core.ac.uk
Background Introduction of human papillomavirus (HPV) vaccination in settings with the
highest burden of HPV is not universal, partly because of the absence of quantitative …
highest burden of HPV is not universal, partly because of the absence of quantitative …
Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study
M Jit, M Brisson, A Portnoy… - The Lancet Global …, 2014 - researchonline.lshtm.ac.uk
Background Introduction of human papillomavirus (HPV) vaccination in settings with the
highest burden of HPV is not universal, partly because of the absence of quantitative …
highest burden of HPV is not universal, partly because of the absence of quantitative …
Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study.
M Jit, M Brisson, A Portnoy, R Hutubessy - 2014 - cabidigitallibrary.org
Background: Introduction of human papillomavirus (HPV) vaccination in settings with the
highest burden of HPV is not universal, partly because of the absence of quantitative …
highest burden of HPV is not universal, partly because of the absence of quantitative …
Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study
M Jit, M Brisson, A Portnoy… - The Lancet. Global …, 2014 - pubmed.ncbi.nlm.nih.gov
Background Introduction of human papillomavirus (HPV) vaccination in settings with the
highest burden of HPV is not universal, partly because of the absence of quantitative …
highest burden of HPV is not universal, partly because of the absence of quantitative …
Cost-effectiveness of female human papillomavirus vaccination in 179 countries: A PRIME modelling study
M Jit, M Brisson, A Portnoy… - The Lancet Global …, 2014 - pure.johnshopkins.edu
Background: Introduction of human papillomavirus (HPV) vaccination in settings with the
highest burden of HPV is not universal, partly because of the absence of quantitative …
highest burden of HPV is not universal, partly because of the absence of quantitative …
[PDF][PDF] Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study
M Jit, M Brisson, A Portnoy, R Hutubessy - 2014 - scholar.archive.org
Background Introduction of human papillomavirus (HPV) vaccination in settings with the
highest burden of HPV is not universal, partly because of the absence of quantitative …
highest burden of HPV is not universal, partly because of the absence of quantitative …
[HTML][HTML] Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study
M Jit, M Brisson, A Portnoy, R Hutubessy - The Lancet Global Health, 2014 - Elsevier
Background Introduction of human papillomavirus (HPV) vaccination in settings with the
highest burden of HPV is not universal, partly because of the absence of quantitative …
highest burden of HPV is not universal, partly because of the absence of quantitative …
Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study.
M Jit, M Brisson, A Portnoy… - The Lancet. Global Health, 2014 - europepmc.org
Background Introduction of human papillomavirus (HPV) vaccination in settings with the
highest burden of HPV is not universal, partly because of the absence of quantitative …
highest burden of HPV is not universal, partly because of the absence of quantitative …